IGM Biosciences’ stock tumbles as analysts weigh in on pivot plan with dismay
Oct 01, 2024
IGM Biosciences Inc.’s stock tumbled 14% Tuesday, as analysts weighed in with dismay on the company’s pivot away from oncology to a focus on autoimmune diseases, with at least two opting to lower their ratings.
https://www.marketwatch.com/story/igm-biosciences-stock-tumbles-as-analysts-weigh-in-on-pivot-plan-with-dismay-81c4bd02?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service